Cargando…
Effective holistic characterization of small molecule effects using heterogeneous biological networks
The two most common reasons for attrition in therapeutic clinical trials are efficacy and safety. We integrated heterogeneous data to create a human interactome network to comprehensively describe drug behavior in biological systems, with the goal of accurate therapeutic candidate generation. The Co...
Autores principales: | Mangione, William, Falls, Zackary, Samudrala, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169664/ https://www.ncbi.nlm.nih.gov/pubmed/37180722 http://dx.doi.org/10.3389/fphar.2023.1113007 |
Ejemplares similares
-
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
por: Mangione, William, et al.
Publicado: (2022) -
352 Computational methods for predicting drug combinations for targeting KRAS mutations relevant to non-small cell lung cancer
por: Bruggemann, Liana, et al.
Publicado: (2022) -
Exploration of interaction scoring criteria in the CANDO platform
por: Falls, Zackary, et al.
Publicado: (2019) -
A Deep-Learning Proteomic-Scale Approach for Drug Design
por: Overhoff, Brennan, et al.
Publicado: (2021) -
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020)